TW329428B - Peptide boronic acid derivatives having serine protease inhibiting activity the invention relates to peptide boronic derivatives having serine protease inhibiting activity which are potent thrombin inhibitors. - Google Patents

Peptide boronic acid derivatives having serine protease inhibiting activity the invention relates to peptide boronic derivatives having serine protease inhibiting activity which are potent thrombin inhibitors.

Info

Publication number
TW329428B
TW329428B TW083102996A TW83102996A TW329428B TW 329428 B TW329428 B TW 329428B TW 083102996 A TW083102996 A TW 083102996A TW 83102996 A TW83102996 A TW 83102996A TW 329428 B TW329428 B TW 329428B
Authority
TW
Taiwan
Prior art keywords
serine protease
inhibiting activity
protease inhibiting
peptide boronic
derivatives
Prior art date
Application number
TW083102996A
Other languages
English (en)
Inventor
Nigel Scott Cook Dr
Rainer Metternich Dr
Carlo Tapparelli Dr
Anette Wienand Dr
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939304289A external-priority patent/GB9304289D0/en
Priority claimed from GB939306822A external-priority patent/GB9306822D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of TW329428B publication Critical patent/TW329428B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TW083102996A 1993-03-03 1994-04-07 Peptide boronic acid derivatives having serine protease inhibiting activity the invention relates to peptide boronic derivatives having serine protease inhibiting activity which are potent thrombin inhibitors. TW329428B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939304289A GB9304289D0 (en) 1993-03-03 1993-03-03 Organic compounds
GB939306822A GB9306822D0 (en) 1993-04-01 1993-04-01 Organic compounds

Publications (1)

Publication Number Publication Date
TW329428B true TW329428B (en) 1998-04-11

Family

ID=26302527

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083102996A TW329428B (en) 1993-03-03 1994-04-07 Peptide boronic acid derivatives having serine protease inhibiting activity the invention relates to peptide boronic derivatives having serine protease inhibiting activity which are potent thrombin inhibitors.

Country Status (18)

Country Link
EP (1) EP0688336B1 (zh)
JP (1) JPH08507501A (zh)
KR (1) KR960701085A (zh)
AT (1) ATE153670T1 (zh)
AU (1) AU677297B2 (zh)
CA (1) CA2153656A1 (zh)
DE (1) DE69403459T2 (zh)
DK (1) DK0688336T3 (zh)
ES (1) ES2101516T3 (zh)
GR (1) GR3023577T3 (zh)
HU (1) HUT72735A (zh)
IL (1) IL108797A0 (zh)
MY (1) MY131622A (zh)
NZ (1) NZ262415A (zh)
PL (1) PL310940A1 (zh)
SG (1) SG52766A1 (zh)
TW (1) TW329428B (zh)
WO (1) WO1994020526A1 (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5574014A (en) * 1988-04-28 1996-11-12 Thrombosis Research Institute Inhibitors of trypsin-like enzymes
US6313096B1 (en) 1988-04-28 2001-11-06 Trigen Limited Inhibitors of trypsin-like enzymes
US6825169B1 (en) 1991-10-22 2004-11-30 Trustees Of Tufts College Inhibitors of dipeptidyl-aminopeptidase type IV
GB9502985D0 (en) * 1995-02-16 1995-04-05 Thrombosis Res Inst Enzyme inhibitors
US5612378A (en) * 1995-06-06 1997-03-18 3-Dimensional Pharmaceuticals, Inc. Bis-arylsulfonylaminobenzamide derivatives and the use thereof as factor Xa inhibitors
US5559150A (en) * 1995-06-06 1996-09-24 3-Dimensional Pharmaceuticals, Inc. N,N-disulfonylated aminobenzene carboxlic acids and the use thereof as thrombin inhibitors
US5741819A (en) * 1995-06-07 1998-04-21 3-Dimensional Pharmaceuticals, Inc. Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitors
US5612369A (en) * 1995-06-07 1997-03-18 3-Dimensional Pharmaceuticals, Inc. Thrombin inhibitors
GB9515489D0 (en) * 1995-07-28 1995-09-27 Sandoz Ltd Organic compounds
US5965532A (en) * 1996-06-28 1999-10-12 Trustees Of Tufts College Multivalent compounds for crosslinking receptors and uses thereof
US6040145A (en) 1997-05-07 2000-03-21 Tufts University Potentiation of the immune response
US6100234A (en) 1997-05-07 2000-08-08 Tufts University Treatment of HIV
NZ503359A (en) 1997-09-29 2002-02-01 Point Therapeutics Inc Method for proliferating haematopoietic cells in vitro in the absence of exogenous cytokines
GB9724786D0 (en) * 1997-11-25 1998-01-21 Danbiosyst Uk Oral delivery system
CA2331122A1 (en) 1998-05-04 1999-11-11 Point Therapeutics, Inc. Hematopoietic stimulation
US6355614B1 (en) 1998-06-05 2002-03-12 Point Therapeutics Cyclic boroproline compounds
US6890904B1 (en) 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
PL376535A1 (pl) 2002-09-09 2006-01-09 Trigen Limited Sole kwasu boronowego i ich zastosowanie w leczeniu zakrzepicy
JP6265583B2 (ja) 2008-10-17 2018-01-24 ウィスコンシン アルムニ リサーチ ファンデイション 生理活性アルファベータペプチドを作製する方法
EP3472151A4 (en) 2016-06-21 2020-03-04 Orion Ophthalmology LLC CARBOCYCLIC PROLINAMIDE DERIVATIVES

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499082A (en) * 1983-12-05 1985-02-12 E. I. Du Pont De Nemours And Company α-Aminoboronic acid peptides
US5187157A (en) * 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
GB9017694D0 (en) * 1990-08-13 1990-09-26 Sandoz Ltd Improvements in or relating to organic chemistry

Also Published As

Publication number Publication date
AU677297B2 (en) 1997-04-17
SG52766A1 (en) 1998-09-28
EP0688336A1 (en) 1995-12-27
AU6208094A (en) 1994-09-26
MY131622A (en) 2007-08-30
HUT72735A (en) 1996-05-28
ES2101516T3 (es) 1997-07-01
HU9501976D0 (en) 1995-09-28
PL310940A1 (en) 1996-01-08
DE69403459D1 (de) 1997-07-03
DE69403459T2 (de) 1998-01-02
IL108797A0 (en) 1994-06-24
DK0688336T3 (da) 1997-10-20
JPH08507501A (ja) 1996-08-13
NZ262415A (en) 1996-10-28
ATE153670T1 (de) 1997-06-15
EP0688336B1 (en) 1997-05-28
CA2153656A1 (en) 1994-09-15
KR960701085A (ko) 1996-02-24
WO1994020526A1 (en) 1994-09-15
GR3023577T3 (en) 1997-08-29

Similar Documents

Publication Publication Date Title
TW329428B (en) Peptide boronic acid derivatives having serine protease inhibiting activity the invention relates to peptide boronic derivatives having serine protease inhibiting activity which are potent thrombin inhibitors.
MY118065A (en) Cleaning compositions
CO5261542A1 (es) Nuevos derivados tripeptidos como inhibidores de la hepatitis c, comprendiendo sus racematos, diasteroisomeros y procedimiento de preparacion
NO2012004I2 (no) l-okso-2-(2,6-dioksopiperidin-3-yl)-4-aminoisoindolin i racemisk form eller R-eller S-isomerer derav
MY137301A (en) Peptide analogs as irreversible interleukin-1b protease inhibitors
KR920004416A (ko) 트롬빈 저해활성을 가지고 있는 화합물
KE3845A (en) Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
MXPA02011466A (es) Derivados de fenilglicina..
TW377350B (en) Peptidic ketones as interleukin-1beta-converting enzyme inhibitors
ATE90107T1 (de) Peptide mit collagenase hemmender wirkung.
IL175319A0 (en) Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof
HK1117541A1 (en) Template-fixed peptidomimeticsas inhibitors of serine proteases
BR0115447A (pt) Inibidores de tripeptìdeo de hepatite c
HRP20080350T3 (en) Preparation of somatostatin peptides
MY133048A (en) Refrigerating machine oil composition, and refrigeration and compressor using the refrigerating machine oil composition.
ATE468381T1 (de) Neuer kraftstoff mit hoher oktanzahl und geringem aromatengehalt
EA200100413A1 (ru) Композиция и способ удаления кислых газов
ES2095255T3 (es) Analogos de sustitucion de peptidos magainina.
DE69907894D1 (de) Azatricyclo[3.3.1.1]decanderivate und diese enthaltende phrmazeutische zubereitungen
ATE10836T1 (de) Peptide und ihre anwendung in der therapeutik.
MX9701734A (es) Novedosos oxidos de acilfosfina.
TW349942B (en) Substituted 2-phenylpyridines, compositions containing same, processes for preparing same and their uses
HUP9901290A2 (hu) Trombin inhibitor hatású polifluor-alkil-triptofánt tartalmazó tripeptidek
EA200200807A1 (ru) Аминокислотные соединения и их применение в качестве ингибиторов nep, ace и ece
FR2788525B1 (fr) Pseudo-peptides phosphiniques, utilisables comme inhibiteurs des metalloproteases a zinc matricielles